Biocept

(OTC) BIOC

Current PriceN/A

Market CapN/A

Since IPO (2014)-100%

5 Year-100%

1 Year+100%

1 Month+100%

Biocept Financials at a Glance

Market Cap

N/A

Revenue (TTM)

-$3.44M

Net Income (TTM)

-$34.90M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

BIOC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biocept

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Samuel D. Riccitelli

Website

www.biocept.com

Headquarters

San Diego, CA 92121, US

BIOC Financials

Key Financial Metrics (TTM)

Gross Margin

-10%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-1%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$2.58M

Operating Income

-$31.98M

EBITDA

-$30.33M

Operating Cash Flow

-$13.29M

Capital Expenditure

-$807.00K

Free Cash Flow

-$14.10M

Cash & ST Invst.

$12.90M

Total Debt

$12.11M

Biocept Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2023YOY CHG

Revenue

$589.00K

-94.4%

Gross Profit

-$1.96M

-175.8%

Gross Margin

-3.33%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$3.63M

+32.8%

EBITDA

-$3.21M

+37.0%

Quarterly Fundamentals

Name

Q2 2023YOY CHG

Net Cash

-$4.96M

-147.4%

Accounts Receivable

$800.00K

-95.4%

Inventory

$551.00K

-75.5%

Long Term Debt

$9.69M

-7.0%

Short Term Debt

$1.91M

-6.8%

Return on Assets

-1.04%

N/A

Return on Invested Capital

-1.26%

N/A

Free Cash Flow

-$3.18M

+25.2%

Operating Cash Flow

-$3.09M

+23.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PHIOPhio Pharmaceuticals Corp.

PHIOPhio Pharmaceuticals Corp.$1.12+0.90%

GBSGBS Inc.

GBSGBS Inc.$0.47-1.58%

ATLNAtlantic International Corp.

ATLNAtlantic International Corp.$1.48-1.67%

TFFPTFF Pharmaceuticals, Inc.

TFFPTFF Pharmaceuticals, Inc.$0.07-60.05%

LFLYLeafly Holdings, Inc.

LFLYLeafly Holdings, Inc.$37.00+0.00%

XAGELongevity Health Holdings Inc.

XAGELongevity Health Holdings Inc.$0.30+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

HKITHitek Global

HKITHitek Global$5.90+3.04%

BBAIBigBear.ai

BBAIBigBear.ai$5.36+0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.77-0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.38-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$86.15+0.02%

MARAMara Holdings

MARAMara Holdings$14.98+0.04%

POETPoet Technologies

POETPoet Technologies$13.67+0.11%

Questions About BIOC

What is the current price of Biocept?

Biocept is trading at N/A per share.

What is the 52-week range for Biocept?

Over the past 52 weeks, Biocept has traded between N/A and N/A.

How much debt does Biocept have?

As of the most recent reporting period, Biocept reported total debt of $12.11M.

How much cash does Biocept have on hand?

Biocept reported $12.90M in cash and cash equivalents in its most recent financial results.

What is Biocept’s dividend yield?

Biocept does not currently have a dividend yield.

Biocept

Biocept Financials at a Glance

BIOC News

Why RH, Biocept, and Lowe's Jumped Today

Why Biocept, Inc. Is Rebounding Big-Time Today

Why Biocept, Inc. Stock Is Plunging Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Biocept

BIOC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Biocept Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIOC

What is the current price of Biocept?

What is the 52-week range for Biocept?

How much debt does Biocept have?

How much cash does Biocept have on hand?

What is Biocept’s dividend yield?

Premium Investing Services